By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Spectrum Pharmaceuticals, Inc. 

157 Technology Drive

Irvine  California  92618  U.S.A.
Phone: 949-788-6700 Fax: 949-788-6706




Company News
Spectrum Pharma (SPPI) Begins Enrolling Patients In Registrational Trial Of SPI-2012, A Novel, Long Acting G-CSF In Patients With Breast Cancer 1/29/2016 9:20:04 AM
Spectrum Pharma (SPPI) Signs A Strategic Partnership With Servier Canada 1/11/2016 1:00:22 PM
Spectrum Pharma (SPPI) Highlights Four Abstracts On SPI-2012 And Poziotinib At The San Antonio Breast Cancer Symposium (SABCS) 12/8/2015 2:14:37 PM
Spectrum Pharma (SPPI) And Onxeo Announce Complete Response In 67% Of Patients With Peripheral T-Cell Lymphoma In Combination Of Belinostat (Beleodaq) And Standard CHOP 12/7/2015 1:32:50 PM
Spectrum Pharma (SPPI) Highlights 18 Abstracts At The 57th Annual Meeting Of The American Society of Hematology In Orlando, Florida, December 5-8, 2015 12/4/2015 10:48:44 AM
Spectrum Pharma (SPPI) Submits Phase 2 Breast Cancer Protocol To FDA As Part Of An Investigational New Drug (IND) Application For Poziotinib 11/20/2015 11:07:02 AM
Spectrum Pharma (SPPI) Divests Rights To ZEVALIN (ibritumomab tiuxetan) In Japan And Select Other Ex-US Countries To Mundipharma AG 11/18/2015 11:19:41 AM
Eagle Pharmaceuticals (EGRX) And Spectrum Pharma (SPPI) Announce Co-Promotion Agreement 11/5/2015 1:01:40 PM
Spectrum Pharma (SPPI) Reports Third Quarter 2015 Financial Results and Pipeline Update 11/5/2015 12:39:18 PM
Spectrum Pharma (SPPI) Announces Third Quarter 2015 Financial Results Teleconference And Webcast 11/2/2015 9:04:01 AM